Drugs / Human insulin isophane
Human insulin isophane
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03507829 Comparator | Nov 2012 → May 2018 | hyperglycemia | Medical University of Vienna | Completed | No outcome recorded |
| Phase 3 | NCT01680185 Comparator | Aug 2012 → May 2018 | hyperglycemia | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human insulin isophane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01680185 ↗ |
| Known as | Humulin N | “the basal insulin arm, treated predominantly with intermediate acting NPH insulin (human insulin isophane, Humulin N, Eli Lilly)” NCT03507829 ↗1“Human insulin isophane, Humulin N (Eli Lilly)” NCT01680185 ↗ |
| Known as | NPH insulin | “the basal insulin arm, treated predominantly with intermediate acting NPH insulin (human insulin isophane, Humulin N, Eli Lilly)” NCT03507829 ↗1“intermediate acting NPH insulin (human insulin isophane, Humulin N, Eli Lilly)” NCT01680185 ↗ |